• category:Business
Norlase secures $11 million following ECHO approval
Business

Norlase secures $11 million following ECHO approval

Announcement follows the recent FDA clearance and CE mark earlier this month.
Ray Therapeutics secures $100 million in funding for optogenetic gene therapy programs
Business

Ray Therapeutics secures $100 million in funding for optogenetic gene therapy programs

Company plans on using funding to target inherited retinal diseases.
Graybug Vision and Mireca terminate IRD partnership
Business

Graybug Vision and Mireca terminate IRD partnership

All intellectual property rights will revert back to Mireca.
Alimera purchases US commercial rights to YUTIQ
Business

Alimera purchases US commercial rights to YUTIQ

Acquisition from EyePoint Pharmaceuticals gives the company exclusive global rights.
New AI company Optain targets retinal imaging
Business

New AI company Optain targets retinal imaging

Aegis Ventures and Northwell Health’s joint company creation platform raises $12 million to support launch.
Astellas Pharma acquires Iveric Bio
Business

Astellas Pharma acquires Iveric Bio

The $5.9 billion deal includes avacincaptad pegol, an investigational therapy for GA.
Ocuphire Pharma ousts CEO; names interim leader
Business

Ocuphire Pharma ousts CEO; names interim leader

Rick Rodgers will serve as CEO on an interim basis.
Brightstar Therapeutics secures financing for groundbreaking corneal disease treatment
Business

Brightstar Therapeutics secures financing for groundbreaking corneal disease treatment

Company plans to launch trials on its BrightMEM corneal allograft; appoints two new ophthalmologists to leadership positions.
Johnson & Johnson Vision announces new regional leaders
Business

Johnson & Johnson Vision announces new regional leaders

Senior industry executives will assume leadership for the company’s Americas, EMEA, and APAC regions.
Eyes On Eyecare acquires Interventional Mindset educational series
Business

Eyes On Eyecare acquires Interventional Mindset educational series

The educational series is geared toward providing ophthalmologists with innovative content and practical skills for mastering new technologies.
CMS lowers cut to 2024 Medicare reimbursement rates
Business

CMS lowers cut to 2024 Medicare reimbursement rates

New rates include a 3.32% growth in total payments and a 1.12% cut in average reimbursement rates.
Novartis is (reportedly) starting to sell its ophthalmology assets
Business

Novartis is (reportedly) starting to sell its ophthalmology assets

Bloomberg reports that Novartis AG is working with an adviser to determine potential sales for its front-of-eye treatment assets.
Pediatric vision screening platform GoCheck Kids names new CEO
Business

Pediatric vision screening platform GoCheck Kids names new CEO

Cloud-based technology has performed over 4 million screenings in the U.S. and Europe.
EyeCheq adds new exec in mission to target early diagnosis of blinding diseases
Business

EyeCheq adds new exec in mission to target early diagnosis of blinding diseases

Jai G. Parekh, MD, MBA, FAAO, joins the developer of the first fully autonomous eye screening platform with artificial intelligence.
Viatris appoints new CEO
Business

Viatris appoints new CEO

Scott A. Smith will assume leadership this spring.
Latinos En Optometry officially launches
Business

Latinos En Optometry officially launches

Non-profit corporation is looking to expand its membership and presence within the eyecare community.
Eyes On Eyecare CEO honored as MM+M’s Top 40 Under 40
Business

Eyes On Eyecare CEO honored as MM+M’s Top 40 Under 40

Matt Geller, CEO and co-founder, Eyes On Eyecare, was named to the prestigious 2022-2023 MM+M Top 40 Under 40 list.
Bausch + Lomb names new (returning) CEO
Business

Bausch + Lomb names new (returning) CEO

Brent Saunders will take the helm, effective March 6.
Nidek and Hoya Vision Care launch global partnership
Business

Nidek and Hoya Vision Care launch global partnership

New agreement focuses on offering patients a wider array of ophthalmic services.
Amazon launches online subscription service for generic drugs
Business

Amazon launches online subscription service for generic drugs

The new service is exclusive to Prime members for a flat rate of $5 per month.